Medical Foods Market Report 2026

The medical foods market size has grown strongly in recent years. It will grow from $24.37 billion in 2025 to $26.26 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing geriatric population, growing awareness of therapeutic nutrition, advancements in medical research, expansion of hospital & clinical infrastructure.

The medical foods market size is expected to see strong growth in the next few years. It will grow to $35.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to technological integration in nutritional monitoring, growth of online & institutional distribution channels, increasing adoption of disease-specific medical foods, rising investments in r&d for functional ingredients, expansion of home healthcare services. Major trends in the forecast period include personalized nutritional solutions, disease-specific formulations, regulatory compliance & safety standards, functional ingredients innovation, growing home healthcare adoption.

The growing geriatric population is significantly contributing to the expansion of the medical foods market. At the molecular and cellular level, aging results from the accumulation of various forms of biomolecular damage over time. This process leads to a gradual decline in functional capacity, an increased susceptibility to disease, and ultimately death. These age-related changes do not occur in a linear or continuous manner and are only loosely associated with an individual’s chronological age. As people age, their reliance on specific nutritional support increases, particularly medical foods, to help manage chronic and age-related health conditions. For example, in October 2025, the World Health Organization (WHO), a Switzerland-based agency responsible for global public health, reported that by 2030, one in six people worldwide will be aged 60 years or older. By 2050, the global population of individuals aged 60 years and above is expected to double, reaching 2.1 billion. Consequently, the rising geriatric population is expected to drive the growth of the medical foods market.

Major companies operating in the medical foods market are concentrating on the development of innovative offerings, such as plant-based, nutritionally complete oral medical nutrition drinks, to address the growing demand for clinically appropriate, lactose-free, allergy-friendly, and environmentally sustainable nutrition options for patients under medical supervision. Plant-based medical nutrition drinks utilize non-dairy protein sources, such as pea and soy, to deliver complete macro- and micronutrient profiles comparable to conventional dairy-based formulations, while enhancing gastrointestinal tolerance and suitability for vegan and milk-allergic patients. For example, in January 2023, Nutricia, a Netherlands-based medical nutrition company, introduced Fortimel PlantBased Energy, its first plant-based Food for Special Medical Purposes (FSMP) designed for the dietary management of disease-related malnutrition. The product provides energy-dense, nutritionally complete nutrition using a pea-and-soy protein blend, supports patients with cow’s-milk protein allergy, is suitable for vegan and flexitarian diets, and is offered in two flavors to improve patient adherence in both clinical and home-care settings.

In July 2023, Pentec Health Inc., a US-based pharmaceutical products and services company, acquired ZOIA Pharma for an undisclosed amount. This acquisition is intended to improve access to a broad portfolio of medical foods for patients with rare conditions, including individuals with phenylketonuria (PKU), who will now have access to the latest PKU GOLIKE family of medical food products. The transaction highlights Pentec’s commitment to expanding its medical food offerings into emerging and underserved areas of clinical nutrition while strengthening its position as a complex care provider. ZOIA Pharma is a US-based medical food company.

Major companies operating in the medical foods market are Nestlé SA, Danone SA, Fresenius Kabi AG, Mead Johnson & Company LLC, Primus Pharmaceuticals Inc., Abbott Nutrition Inc., Accera Inc., Ajinomoto Cambrooke Inc., Applied Food Sciences Inc., Cambrooke Therapeutics Inc., Danone Nutricia North America Inc., Health and Happiness (H&H) Group Limited, RFI Ingredients LLC, Solace Nutrition LLC, Targeted Medical Pharma Inc., VAYA Pharma Inc., Baxter Healthcare Corporation, Braun Melsungen AG, DuPont Nutrition & Biosciences, Enteral Nutrition Holdings Inc., Fresenius Medical Care AG & Co. KGaA, Nutricia North America Inc., Otsuka Pharmaceutical Co. Ltd., Koninklijke DSM NV, Total Parenteral Nutrition Solutions Inc.

North America was the largest region in the medical foods market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical foods market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical foods market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the medical foods market by increasing import costs for raw ingredients and specialized formulations, which affects production expenses and supply chain efficiency. Segments like powder formulations and pills, particularly in regions such as North America and Europe, are most impacted due to reliance on international sourcing. While tariffs can increase costs, they may also encourage local manufacturing and innovation in cost-effective formulations, boosting domestic production and potentially creating more resilient supply chains.

The medical foods market research report is one of a series of new reports that provides medical foods market statistics, including medical foods industry global market size, regional shares, competitors with a medical foods market share, detailed medical foods market segments, market trends and opportunities, and any further data you may need to thrive in the medical foods industry. This medical foods market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical foods are foods formulated to be consumed orally under the supervision of a physician and are intended to meet specific dietary requirements. They are designed to help manage existing diseases or medical conditions through targeted nutritional support. Medical foods are exempt from standard labeling requirements related to nutrition content and health claims.

The main types of medical foods include pills, powders, and others. Medical food pills are small pellets or tablets, often coated, that are taken by swallowing whole or by chewing. These pills are specially developed to address the nutritional needs of patients with various medical conditions, such as depression, attention-deficit/hyperactivity disorder (ADHD), and others. They are used in the treatment of Alzheimer’s disease, diabetic neuropathy, nutritional deficiencies, ADHD, and other conditions, and are distributed through online, retail, and institutional sales channels.

The medical foods market consists of sales of oral rehydration products, amino acids, and probiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.